Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03500419 · ClinicalTrials.gov registry record · NA
Penile Length Maintenance Post-Prostatectomy
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 82
- Enrollment target
NCT03500419: Completed NA study, sponsored by Mayo Clinic.
NCT03500419 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 82 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03500419, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 82 participants
- Enrollment target
Study Summary
The objective of the current study is to evaluate the efficacy of a novel, class I (ie. lowest risk, clinical studies not required) medical penile traction device in preventing loss of penile length in men undergoing robotic-assisted prostatectomy.
Interventions
- OTHER No treatment
- DEVICE RestoreX
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2018-03-23 |
| Est. Completion | 2020-12-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03500419
The ClinicalTrials.gov registry entry for NCT03500419 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which No treatment is the first listed.
NCT03500419 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03500419 about?
NCT03500419 is a clinical study titled "Penile Length Maintenance Post-Prostatectomy". The objective of the current study is to evaluate the efficacy of a novel, class I (ie. lowest risk, clinical studies not required) medical penile traction device in preventing loss of penile length in men undergoing robotic-assisted prostatectomy.
What is the current status of trial NCT03500419?
This trial is currently completed. It is a NA study. The enrollment target is 82 participants. The study started on 2018-03-23. Estimated completion is 2020-12-28.
What interventions are being tested in trial NCT03500419?
The interventions under investigation include: No treatment (OTHER), RestoreX (DEVICE).
Who is sponsoring clinical trial NCT03500419?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.